Non-Alcoholic Fatty Liver Disease Fibrosis Score Predicts Hematological Toxicity of Chemotherapy Including Irinotecan for Colorectal Cancer

Molecular and Clinical Oncology- United Kingdom

doi 10.3892/mco.2017.1177

Full Text

Abstract

Available in

Categories

Cancer Research

Date

March 1, 2017

Authors

Masashi Tsuruta

Hirotoshi Hasegawa

Koji Okabayashi

Publisher

Spandidos Publications

Related search

Portal Lymphadenopathy Predicts Non-Alcoholic Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease

Multidisciplinary

English

Non-Invasive Diagnosis of Fibrosis in Non-Alcoholic Fatty Liver Disease

Journal of Clinical and Experimental Hepatology

English

Current Modalities of Fibrosis Assessment in Non-Alcoholic Fatty Liver Disease

Journal of Clinical and Translational Hepatology

English

Clinical Impact of Non-Alcoholic Fatty Liver Disease on the Occurrence of Colorectal Neoplasm: Propensity Score Matching Analysis

Multidisciplinary

English

Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

Multidisciplinary

English

Treatment of Non-Alcoholic Fatty Liver Disease

Postgraduate Medical Journal

English

Non-Alcoholic Fatty Liver Disease and Disease Mongering

American Journal of Medicine

English

Sarcopenia Is Associated With Severe Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD)

Internal Medicine

English